Evidence map›Paper›PMID 40383760›Full record

ArticleBiomedical engineering online2025

Design, construction, and deployment of a multi-locus transcranial magnetic stimulation system for clinical use.

Heikki Sinisalo, Olli-Pekka Kahilakoski, Victor H Souza, Jaakko O Nieminen, Robin Rantala, Timo Tommila, Isabel Usuga, Mikael Laine, Oskari Ahola, Eva Gallegos and 13 more

Abstract read
In one paragraph

Article in Biomedical engineering online, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Heikki Sinisalo *Department of Neuroscience and Biomedical Engineering, Aalto University School of Science, Espoo, Finland. heikki.sinisalo@aalto.fi.
Olli-Pekka Kahilakoski *Department of Neuroscience and Biomedical Engineering, Aalto University School of Science, Espoo, Finland.
Victor H SouzaDepartment of Neuroscience and Biomedical Engineering, Aalto University School of Science, Espoo, Finland.
Jaakko O NieminenDepartment of Neuroscience and Biomedical Engineering, Aalto University School of Science, Espoo, Finland.
Robin RantalaDepartment of Neuroscience and Biomedical Engineering, Aalto University School of Science, Espoo, Finland.
Timo TommilaDepartment of Neuroscience and Biomedical Engineering, Aalto University School of Science, Espoo, Finland.
Isabel UsugaDepartment of Neuroscience and Biomedical Engineering, Aalto University School of Science, Espoo, Finland.
Mikael LaineDepartment of Neuroscience and Biomedical Engineering, Aalto University School of Science, Espoo, Finland.
Oskari AholaDepartment of Neurology & Stroke, University of Tübingen, Tübingen, Germany.
Eva GallegosDepartment of Neuroscience and Biomedical Engineering, Aalto University School of Science, Espoo, Finland.
Gábor KozákDepartment of Neurology & Stroke, University of Tübingen, Tübingen, Germany.
David Emanuel VetterDepartment of Neurology & Stroke, University of Tübingen, Tübingen, Germany.
Ilkka RissanenDepartment of Neuroscience and Biomedical Engineering, Aalto University School of Science, Espoo, Finland.
Andreas JooßDepartment of Neurology & Stroke, University of Tübingen, Tübingen, Germany.
Renan MatsudaDepartment of Neuroscience and Biomedical Engineering, Aalto University School of Science, Espoo, Finland.
Ana M SotoDepartment of Neuroscience and Biomedical Engineering, Aalto University School of Science, Espoo, Finland.
Dezhou LiDepartment of Neuroscience and Biomedical Engineering, Aalto University School of Science, Espoo, Finland.
Dania HumaidanDepartment of Neurology & Stroke, University of Tübingen, Tübingen, Germany.
Matti StenroosDepartment of Neuroscience and Biomedical Engineering, Aalto University School of Science, Espoo, Finland.
Timo RoineDepartment of Neuroscience and Biomedical Engineering, Aalto University School of Science, Espoo, Finland.
Dubravko KičićDepartment of Neuroscience and Biomedical Engineering, Aalto University School of Science, Espoo, Finland.
Ulf ZiemannDepartment of Neurology & Stroke, University of Tübingen, Tübingen, Germany.
Risto J IlmoniemiDepartment of Neuroscience and Biomedical Engineering, Aalto University School of Science, Espoo, Finland.

Funding

Business Finland 1752/31/2020European Research Council 810377Novo Nordisk NNF22OC0080883Research Council of Finland 294625Research Council of Finland 349985
6 · The paper itself

Abstract

backgroundTranscranial magnetic stimulation (TMS) is an established method for noninvasive brain stimulation, used for investigating and treating brain disorders. Recently, multi-locus TMS (mTMS) has expanded the capabilities of TMS by employing an array of overlapping stimulation coils, enabling delivery of stimulation pulses at different cortical locations without physical coil movement. We aimed to design, construct, and deploy an mTMS device and a five-coil array for clinical environment, emphasizing safety of the system.

methodsOur mTMS device is controlled by a field-programmable gate array (FPGA). The power electronics comprises five stimulation channels, each consisting of a high-voltage capacitor connected to a pulse circuit, controlling a single coil in the array. The device contains custom-designed circuit boards, with functions such as monitoring the system state, reporting errors, and delivering pulses. Our design utilizes redundancy in both hardware and firmware to ensure robust operation and safety. We performed an automated motor mapping test to verify the electronic targeting capabilities of the device.

resultsWe constructed the mTMS device and deployed it to the Hertie Institute for Clinical Brain Research (Tübingen, Germany). Compared to our earlier prototype, the new design improves patient and operator safety. The motor mapping test confirmed that our device can accurately target stimulation pulses in the cortex. SIGNIFICANCE: mTMS or other similar technologies are currently not available for hospital use. The present device and its installation are major steps toward establishing multicoil TMS as an accessible clinical tool for investigation and treatment of the brain.

Indexed as

Transcranial Magnetic StimulationEquipment DesignHumansFunctional imagingMotor mappingmTMSPatient safetyTranscranial magnetic stimulation

Identifiers

PMID40383760
PMCPMC12085834

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.